Literature DB >> 31488436

Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia.

Brian M Barth1,2,3, Weiyuan Wang1, Paul T Toran1, Todd E Fox4,5, Charyguly Annageldiyev2,3, Regina M Ondrasik2,3, Nicole R Keasey2,3, Timothy J Brown2,3,6, Viola G Devine2,3, Emily C Sullivan1, Andrea L Cote1, Vasiliki Papakotsi1, Su-Fern Tan2,3,7,8, Sriram S Shanmugavelandy4, Tye G Deering5, David B Needle1, Stephan T Stern9, Junjia Zhu10, Jason Liao10, Aaron D Viny11, David J Feith2,3,7,8, Ross L Levine11, Hong-Gang Wang3,4,12, Thomas P Loughran2,3,7,8, Arati Sharma2,3,4, Mark Kester3,4,5,8,13, David F Claxton2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31488436      PMCID： PMC6737412          DOI： 10.1182/bloodadvances.2018021295

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  24 in total

Review 1.  Ceramide-based therapeutics for the treatment of cancer.

Authors:  Brian M Barth; Myles C Cabot; Mark Kester
Journal:  Anticancer Agents Med Chem       Date:  2011-11       Impact factor: 2.505

2.  Extracts of Devil's club (Oplopanax horridus) exert therapeutic efficacy in experimental models of acute myeloid leukemia.

Authors:  Colin M McGill; Estefania J Alba-Rodriguez; Shuo Li; Charles J Benson; Regina M Ondrasik; Lindsey N Fisher; David F Claxton; Brian M Barth
Journal:  Phytother Res       Date:  2014-09       Impact factor: 5.878

Review 3.  Ceramide-orchestrated signalling in cancer cells.

Authors:  Samy A F Morad; Myles C Cabot
Journal:  Nat Rev Cancer       Date:  2012-12-13       Impact factor: 60.716

4.  Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

Authors:  Jay P Patel; Mithat Gönen; Maria E Figueroa; Hugo Fernandez; Zhuoxin Sun; Janis Racevskis; Pieter Van Vlierberghe; Igor Dolgalev; Sabrena Thomas; Olga Aminova; Kety Huberman; Janice Cheng; Agnes Viale; Nicholas D Socci; Adriana Heguy; Athena Cherry; Gail Vance; Rodney R Higgins; Rhett P Ketterling; Robert E Gallagher; Mark Litzow; Marcel R M van den Brink; Hillard M Lazarus; Jacob M Rowe; Selina Luger; Adolfo Ferrando; Elisabeth Paietta; Martin S Tallman; Ari Melnick; Omar Abdel-Wahab; Ross L Levine
Journal:  N Engl J Med       Date:  2012-03-14       Impact factor: 91.245

Review 5.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

6.  Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors.

Authors:  Mahadeo A Sukhai; Swayam Prabha; Rose Hurren; Angela C Rutledge; Anna Y Lee; Shrivani Sriskanthadevan; Hong Sun; Xiaoming Wang; Marko Skrtic; Ayesh Seneviratne; Maria Cusimano; Bozhena Jhas; Marcela Gronda; Neil MacLean; Eunice E Cho; Paul A Spagnuolo; Sumaiya Sharmeen; Marinella Gebbia; Malene Urbanus; Kolja Eppert; Dilan Dissanayake; Alexia Jonet; Alexandra Dassonville-Klimpt; Xiaoming Li; Alessandro Datti; Pamela S Ohashi; Jeff Wrana; Ian Rogers; Pascal Sonnet; William Y Ellis; Seth J Corey; Connie Eaves; Mark D Minden; Jean C Y Wang; John E Dick; Corey Nislow; Guri Giaever; Aaron D Schimmer
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

7.  Use of high performance liquid chromatography-electrospray ionization-tandem mass spectrometry for the analysis of ceramide-1-phosphate levels.

Authors:  Dayanjan S Wijesinghe; Jeremy C Allegood; Luciana B Gentile; Todd E Fox; Mark Kester; Charles E Chalfant
Journal:  J Lipid Res       Date:  2009-08-04       Impact factor: 5.922

8.  Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer models.

Authors:  Pavan P Adiseshaiah; Jeffrey D Clogston; Christopher B McLeland; Jamie Rodriguez; Timothy M Potter; Barry W Neun; Sarah L Skoczen; Sriram S Shanmugavelandy; Mark Kester; Stephan T Stern; Scott E McNeil
Journal:  Cancer Lett       Date:  2013-05-07       Impact factor: 8.679

9.  NUP98-HOX translocations lead to myelodysplastic syndrome in mice and men.

Authors:  Christopher Slape; Ying Wei Lin; Helge Hartung; Zhenhua Zhang; Linda Wolff; Peter D Aplan
Journal:  J Natl Cancer Inst Monogr       Date:  2008

Review 10.  The therapeutic potential of nanoscale sphingolipid technologies.

Authors:  Jody L Hankins; Ushma A Doshi; Jeremy K Haakenson; Megan M Young; Brian M Barth; Mark Kester
Journal:  Handb Exp Pharmacol       Date:  2013
View more
  8 in total

1.  Ceramide: improving Bcl-2 inhibitor therapy.

Authors:  Brian M Barth
Journal:  Blood       Date:  2022-06-30       Impact factor: 25.476

2.  Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia.

Authors:  Kelsey H Fisher-Wellman; James T Hagen; Miki Kassai; Li-Pin Kao; Margaret A M Nelson; Kelsey L McLaughlin; Hannah S Coalson; Todd E Fox; Su-Fern Tan; David J Feith; Mark Kester; Thomas P Loughran; David F Claxton; Myles C Cabot
Journal:  FASEB J       Date:  2022-01       Impact factor: 5.834

Review 3.  Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia.

Authors:  Johnson Ung; Su-Fern Tan; Todd E Fox; Jeremy J P Shaw; Luke R Vass; Pedro Costa-Pinheiro; Francine E Garrett-Bakelman; Michael K Keng; Arati Sharma; David F Claxton; Ross L Levine; Martin S Tallman; Myles C Cabot; Mark Kester; David J Feith; Thomas P Loughran
Journal:  Blood Rev       Date:  2022-04-09       Impact factor: 10.626

4.  Inhibition of Lysosomal Function Mitigates Protective Mitophagy and Augments Ceramide Nanoliposome-Induced Cell Death in Head and Neck Squamous Cell Carcinoma.

Authors:  Jeremy J P Shaw; Timothy L Boyer; Emily Venner; Patrick J Beck; Tristen Slamowitz; Tara Caste; Alexandra Hickman; Michael H Raymond; Pedro Costa-Pinheiro; Mark J Jameson; Todd E Fox; Mark Kester
Journal:  Mol Cancer Ther       Date:  2020-10-21       Impact factor: 6.261

5.  Sphingosine-1-phosphate receptor 3 potentiates inflammatory programs in normal and leukemia stem cells to promote differentiation.

Authors:  Kerstin B Kaufmann; Weijia Wang; Michelle Chan-Seng-Yue; Stephanie Z Xie; Olga I Gan; Elisa Laurenti; Laura Garcia-Prat; Shin-Ichiro Takayanagi; Stanley W K Ng; ChangJiang Xu; Andy G X Zeng; Liqing Jin; Jessica McLeod; Elvin Wagenblast; Amanda Mitchell; James A Kennedy; Qiang Liu; Héléna Boutzen; Melissa Kleinau; Joseph Jargstorf; Gareth Holmes; Yang Zhang; Veronique Voisin; Gary D Bader; Jean C Y Wang; Yusuf A Hannun; Chiara Luberto; Timm Schroeder; Mark D Minden; John E Dick
Journal:  Blood Cancer Discov       Date:  2020-12-01

6.  Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia.

Authors:  Andrei V Khokhlatchev; Arati Sharma; Tye G Deering; Jeremy J P Shaw; Pedro Costa-Pinheiro; Upendarrao Golla; Charyguly Annageldiyev; Myles C Cabot; Mark R Conaway; Su-Fern Tan; Johnson Ung; David J Feith; Thomas P Loughran; David F Claxton; Todd E Fox; Mark Kester
Journal:  FASEB J       Date:  2022-10       Impact factor: 5.834

7.  A nano-enhanced vaccine for metastatic melanoma immunotherapy.

Authors:  Katelyn E Salotto; Walter C Olson; Karlyn E Pollack; Anuradha Illendula; Elishama Michel; Sydney Henriques; Todd Fox; Susan Walker; Marya Dunlap-Brown; Craig L Slingluff; Mark Kester; Helena W Snyder
Journal:  Cancer Drug Resist       Date:  2022-07-07

Review 8.  The Role of Ceramide Metabolism and Signaling in the Regulation of Mitophagy and Cancer Therapy.

Authors:  Megan Sheridan; Besim Ogretmen
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.